Skip to content
healthcare.dev

Doxorubicin Hydrochloride Liposome

NDC 0338-0086, Doxorubicin Hydrochloride Liposome, injection, suspension, liposomal, from Baxter Healthcare Company.

Product NDC
0338-0086
Status
Listed
Labeler
Baxter Healthcare Company
Dosage form
INJECTION, SUSPENSION, LIPOSOMAL
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA050718
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0086 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXORUBICIN HYDROCHLORIDE2 mg/mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
0338-0086-01003380086011 VIAL, SINGLE-USE in 1 CARTON (0338-0086-01) / 25 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cf25a018-e795-49e4-8533-a581f8366dd9

Use it

Look up 0338-0086 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0338-0086 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0338-0086. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.